MMP9 and ovarian carcinoma: Inhibition of CRM1-mediated nuclear export has been demonstrated to enhance the accumulation of mTOR in the nucleus, resulting in decreased protein levels of mTOR and its downstream targets, STAT3 and MMP9, in ovarian cancer cells.22